-
The durability of mitral valve repair is not constant, and the progressive incidence of more than trivial regurgitation needs to be considered in selecting a strategy for treating chronic mitral regurgitation.
-
The lipid-lowering arm of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) was initially reported at the American College of Cardiology meeting in Chicago in March and subsequently in Lancet.
-
Greenfield RH. Green tea and prostate cancer. Altern Med Alert 2003;6(6):72.
-
The following questions and answers provide information about the clinical trial questions most frequently asked by patients.
-
Brinker F. Oregon grape root extract for psoriasis. Altern Med Alert 2003;6(6):69-72.
-
O'Mathuna DP. The placebo affect and alternative therapies. Altern Med Alert 2003;6(6):61-69.
-
-
The Women's Health Initiatives (WHI) was halted 1 year ago, but fallout from this landmark study continues. The study was designed to identify the risks or benefits of estrogen plus progesterone vs placebo in healthy postmenopausal women.
-
-
Developing a research survey instrument is a lengthy and complicated process, says Daniel P. Sulmasy, OFM, MD, PhD, of the John J. Conley Department of Ethics at Saint Vincents Hospital in Manhattan. Sulmasy and several colleagues spent five years developing an instrument that elicits ratings of quality and satisfaction with care from medical inpatients, especially those near the end of life.